1. Academic Validation
  2. Self-assembling Releasable Thiocolchicine-Diphenylbutenylaniline Conjugates

Self-assembling Releasable Thiocolchicine-Diphenylbutenylaniline Conjugates

  • ACS Med Chem Lett. 2019 Jan 4;10(4):611-614. doi: 10.1021/acsmedchemlett.8b00605.
Gaia Fumagalli 1 Laura Polito 2 Eleonora Colombo 1 Francesca Foschi 1 Michael S Christodoulou 1 Francesco Galeotti 3 Dario Perdicchia 1 Ivan Bassanini 4 Sergio Riva 4 Pierfausto Seneci 1 Aída García-Argáez 5 6 Lisa Dalla Via 5 Daniele Passarella 1
Affiliations

Affiliations

  • 1 Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy.
  • 2 CNR-ISTM, Via G. Fantoli 16/15, 20138 Milano, Italy.
  • 3 CNR-ISMAC, Via A. Corti 12, 20133 Milano, Italy.
  • 4 Istituto di Chimica del Riconoscimento Molecolare-C.N.R.-ICRM, Via Mario Bianco 9, 20131 Milano, Italy.
  • 5 Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, Via F. Marzolo 5, 35131 Padova, Italy.
  • 6 Fondazione per la Biologia e la Medicina della Rigenerazione T.E.S.-Tissue Engineering and Signalling Onlus, Via F. Marzolo 13, 35131 Padova, Italy.
Abstract

The design and the synthesis of new self-assembling conjugates is reported. The target compounds are characterized by the presence of a self-immolative linker that secures a controlled release induced by Lipase cleavage. 4-(1,2-Diphenylbut-1-en-1-yl)aniline is used as a self-assembling inducer and amino-thiocolchicine as prototype of drug. The release of thiocolchicine derivative has been demonstrated in vitro in the presence of porcine pancreatic Lipase and Celite-supported Lipase. The formation of nanoparticles is confirmed by dynamic light scattering, atomic force microscopy, and fluorescence microscopy. The antiproliferative activity has been proved on two human Cancer cell lines.

Figures